The diagnostic value of PSMA PET/CT in men with newly diagnosed unfavorable intermediate-risk prostate cancer
MJ Hagens, WI Luining, A Jager… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Our objective was to determine the diagnostic value of prostate-specific membrane antigen
(PSMA) PET/CT in staging men with newly diagnosed unfavorable intermediate-risk prostate …
(PSMA) PET/CT in staging men with newly diagnosed unfavorable intermediate-risk prostate …
Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and 68Ga‐PSMA‐PET …
Y Wang, Y Tang, X Gao, Y Gan, S Hu, MF Chen… - The …, 2022 - Wiley Online Library
Background At present, standardized parameters for quantitatively evaluating 68Ga‐PSMA‐
PET/CT outcomes when diagnosing lymph node metastasis in prostate cancer patients are …
PET/CT outcomes when diagnosing lymph node metastasis in prostate cancer patients are …
Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical …
N Coskun, MO Kartal, AS Erdogan… - Nuclear medicine …, 2022 - journals.lww.com
Objective To develop a nomogram based on commonly used clinical data for predicting the
likelihood of metastasis in gallium-68 prostate-specific membrane antigen PET/computed …
likelihood of metastasis in gallium-68 prostate-specific membrane antigen PET/computed …